Sunshine Biopharma Inc. is a Colorado corporation with head offices in Montreal, Canada. The Company is fully reporting in the U.S. (www.SEC.gov) and Canada (www.SEDAR.com). Sunshine Biopharma’s Common Shares are traded on the OTC market under the ticker symbol SBFM. Until recently, we have been operating as a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. Following our recent entry and expansion into the generic pharmaceuticals business, we have become a fully integrated pharmaceutical company offering generic and proprietary drugs for the treatment of cancer and other acute and chronic indications. Our initial proprietary drug candidate, Adva-27a, is a small molecule that has proven effective against different types of multidrug resistant cancer including breast cancer cells (MCF-7/MDR), small-cell lung cancer cells (H69AR), uterine carcinoma cells (MES-SA/Dx5) and pancreatic cancer cells (Panc-1).
January 4, 2018
Sunshine Biopharma Completes the Acquisition of Atlas Pharma